Cited by 39Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsCancer-related cognitive impairment studies

Functional imaging predicts cognitive decline in Alzheimer's disease.

Jagust, W. J., Haan, M. N., Eberling, J. L., Wolfe, N., Reed, B. R.·1996·Journal of Neuroimaging

Abstract

Eighteen patients with Alzheimer's disease were studied with positron emission tomographic measurements of regional cerebral metabolism of glucose. All patients were initially diagnosed and evaluated, underwent positron emission tomography, and then were followed with annual reevaluations, at which time the Mini-Mental State Examination (MMSE) was performed. Patients were followed for an average of 2.5 years, and the rate of cognitive decline was calculated by determining the rate of change in the MMSE score defined as the MMSE score at the initial evaluation minus the MMSE score at the last examination, divided by the number of months between testing. The regional cerebral metabolic rates for glucose determined at the time of the first MMSE were then regressed on these changes in scores. Results showed that glucose metabolic rates in posterior temporal and primary visual cortex regions were significantly correlated with the subsequent rate of cognitive deterioration. These associations were not confounded by age, length of follow-up, baseline MMSE score, or education. Stratification on gender suggested that these associations were much stronger in women than in men. These results replicate previous findings showing that functional brain imaging is predictive of the rate of cognitive decline in Alzheimer's disease.

Integrity signals

Registry

Crossref · 10.1111/jon199663156

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Occipital regions are also atrophic in this study, although changes are not always detected in metabolic or perfusion studies of Alzheimer's disease.

    “Occipital regions are also atrophic in this study; changes are not always detected in metabolic or perfusion studies of AD, in which visual cortices often serve as a control region in PET or single photon emission computed tomography imaging studies (Jagust et al., 1996).”

    From Dynamics of Gray Matter Loss in Alzheimer's Disease (2003) · cites this paper as Jagust et al., 1996

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Jagust, W. J., Haan, M. N., Eberling, J. L., Wolfe, N., & Reed, B. R.
Affiliations
  • Lawrence Berkeley National Laboratory (US)
  • University of California, Davis (US)
Venue
Journal of Neuroimaging
Publisher
Wiley
Published
1996-07
Volume
6
Issue
3
Pages
156-160
ISSN
  • 1051-2284 (ISSN-L)
  • 1552-6569
OpenAlex
W2416046030
Cited by
39
References
15
Citations by year
2025: 1 · 2024: 1 · 2022: 1 · 2021: 1 · 2020: 1 · 2017: 1 · 2016: 1 · 2015: 1 · 2014: 2 · 2013: 1
FWCI
0.94
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Neuroimaging (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01ag007793-08)
  • National Institute on Aging (P30AG010129, AG07793, AG-10129, R03AG033751)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK060753)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cancer-related cognitive impairment studies
Keywords
Alzheimer's disease, cognitive decline, regional cerebral glucose metabolism, positron emission tomography, posterior temporal cortex, primary visual cortex, Mini-Mental State Examination, sex differences
MeSH terms
Age Factors, Aged, Alzheimer Disease, Brain, Cognition, Cognition Disorders, Educational Status, Female, Follow-Up Studies, Forecasting, Glucose, Humans, Male, Mental Status Schedule, Sex Factors, Temporal Lobe, Tomography, Emission-Computed, Visual Cortex

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review